Immunic (IMUX) director Duane Nash resigns; board cut to 9 members

IMMUNIC, INC.

Dr. Duane Nash resigned from the Immunic Board of Directors effective September 10, 2026.
Resignation was not related to any disagreement with company operations, policies, or practices.
Board size reduced from ten to nine members via Board resolution.
Company expressed gratitude for Dr. Nash's service and contributions.

item 5.02 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Dr. Duane Nash

Member of the Board of Directors

IMUX · IMMUNIC, INC.

Effective: 2026-09-10
Filed: September 11, 2026, 5:24 PM ET

On September 10, 2026, Dr. Duane Nash resigned as a member of the Board of Directors (the “Board”) of Immunic, Inc., a Delaware corporation (the “Company”).

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Dr. Duane Nash resigned as Member of the Board of Directors at IMMUNIC, INC..

Action: resigned
Role: Member of the Board of Directors

Exact text from the filing

On September 10, 2026, Dr. Duane Nash resigned as a member of the Board of Directors (the “Board”) of Immunic, Inc., a Delaware corporation (the “Company”).

View on SEC.gov

IMMUNIC, INC. filing history →

Source: SEC EDGAR

accession 0001193805-26-001219

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.